Report Overview

The EU Acne Medicine market size stood at round USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Acne or acne vulgaris is one of the most common skin conditions majorly caused by changes in skin structures. It affects millions of adolescents across the world. It is characterized by pimples, blackheads, oily skin, and scarring. It generally affects skin with comparatively high number of sweat glands such as upper part of chest, back, and face



Market Drivers

Growing pollution levels in the European countries increases the incidence of skin dryness among the public and their unhealthy lifestyles to majorly boost the growth of the Acne
Medication market in Europe. Increasing population and surging demand for the utilization of acne products in the market are accelerating the growth. Funds and investments available for the research and developments of acne products, enormous patient population, and the growing teenage population are likely to stimulate market growth. Around 507 million residents are there in the European region, according to Eurostat in 2014, and amid the
population, 79 million are children growing up to 14 years of age